Mannatech Prepared for New Law that will Require Reporting of Adverse Events with Consumption of Dietary Supplements

Share Article

Global health and wellness provider Mannatech, Incorporated, is prepared to meet the requirements of a new law designed by Congress to boost consumer confidence in the safety of dietary supplements.

Our Good Manufacturing Practices and safety monitoring systems give consumers the confidence they need to know they are getting the best and safest products.

Past News Releases

RSS

Global health and wellness provider Mannatech, Incorporated (NASDAQ-MTEX) is prepared to meet the requirements of a new law designed by Congress to boost consumer confidence in the safety of dietary supplements.

The bill, which will become effective within a year of being signed into law, will require supplement companies to include contact information on product labels for consumers to report adverse events during consumption. The bill received bipartisan support in both the U.S. Senate, which passed the bill unanimously, and the U.S. House of Representatives, which approved it by more than a 2-to-1 majority.

Mannatech has operated a product safety monitoring program for more than eight years. Modeled after programs used by the prescription drug industry, Mannatech's safety monitoring is designed to record any possible adverse event reported to the company in its international and domestic markets.

"Mannatech's impeccable safety record is a direct result of our stringent control programs," said company founder, CEO and chairman of the board, Sam Caster. "Our Good Manufacturing Practices and safety monitoring systems give consumers the confidence they need to know they are getting the best and safest products."

Given its legacy of monitoring the safety of its products, Mannatech believes the company has systems in place that will comply with the new law. In fact, the company already complies with similar requirements in some of its international markets.

Founded in 1993, Mannatech is a leading wellness company and a pioneer in the field of proprietary glyconutritional supplements and wellness products. The company announced a ground-breaking formulation in 1996 of a nutritional supplement comprised of a unique blend of plant-based saccahrides, which are also known as glyconutrients ('glyco' is the Greek word for 'sweet').

Medical research acknowledges that certain sugars are needed at the cellular level for optimum cellular function.* Considering that most of these sugars are often lacking in modern diets, Mannatech sought new and better sources of these nutrients. The effort culminated in 1996 with the Ambrotose complex.

Ten years of research, including in vitro studies, animal studies, human case reports and human clinical studies suggest that Ambrotose provides a wide range of benefits. More than 20 patents worldwide - including one from the U.S. Patent and Trademark Office - have been issued to Mannatech for technology related to the Ambrotose formulation.

Today Mannatech has more than two dozen glyconutritional products for adults and children that address health and nutrition, sports performance, weight management and skin care.

About Mannatech, Incorporated

Mannatech, Incorporated, is a global wellness solutions provider that develops innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products that are sold through approximately 536,000 independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark and Germany.

For additional information about Mannatech, please visit http://www.mannatech.com.

Media may contact Alan A. Van Zelfden at 972-471-7334 or by e-mail.

  • These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified generally by the use of phrases or terminology such as "scheduled," "believes," and "plans" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that its expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions its readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Alan A. Van Zelfden
Visit website